Welcome : Guest
  • Only Report Titles
  • Titles & Keywords

GENETIC TESTING - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Genetic Testing in US$ Million. The US market is analyzed by the following segments: Prenatal and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets. The report profiles 77 Companies including many key and niche players such as Abbott Laboratories, Abbott Molecular, Inc., Applied Biosystems Inc., AutoGenomics, Inc., BioRad Laboratories, Celera Group, Clinical Data, Inc., Orchid Cellmark, Inc., PerkinElmer, Inc., Quest Diagnostics, Inc., Roche Diagnostics Corp. and Roche Molecular Diagnostics, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Code : MCP-1392
Price : $4500
Companies : 77
Pages : 351
Date : January 2011
Market Data Tables : 20

Complimentary Report Insights:


Request a Complimentary Copy of the Study’s Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS

  GENETIC TESTING (Complete Report) Pages : 351   | $4500
 
  1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS.......14 $295  
   Study Reliability and Reporting Limitations.......1  
   Disclaimers.......2
Data Interpretation & Reporting Level.......2
  
   Quantitative Techniques & Analytics.......3
Product Definitions and Scope of Study.......3
Prenatal Diagnosis.......3
  
   Newborn Screening.......4
Pharmacogenetics/Pharmacogenomics.......4
Predictive Testing.......4
  
  2. OVERVIEW.......56 $950  
   Progressing from Service Driven to Product-Driven Market.......5
Genetic Testing: The Rapidly Growing Segment of Molecular Diagnostics Market.......5
Table 1: Worldwide In-Vitro Diagnostics Market by Segment (2008) – Percentage Breakdown of Value Sales for Immunochemistry, Diabetes, Clinical Chemistry, Point-of-Care Testing, Molecular Diagnostics, Hematology, Coagulation, and Others (includes corresponding Graph/Chart).......5
1$350
   Table 2: World In-Vitro Diagnostic (IVD) Market by Leading Players (2008): Market Share Breakdown for Roche, Siemens, Abbott Diagnostics, Becton Dickinson, Beckman Coulter, OCD , BioMerieux, Sysmex, and Others (includes corresponding Graph/Chart).......6

Table 3: World Molecular Diagnostics Market (2007-2015): Key Segments [Oncology, Genetic Testing, Blood Screening, and Infectious Disease Testing] Ranked by Growth (includes corresponding Graph/Chart).......6
Genetic Testing Outlook Brightens.......6
1$350
   Issues & Trends Affecting the Market.......7
Challenges Faced.......7
Genetic Counseling: Gaining Momentum.......7
Online Approach Gains Momentum.......7
1$100
   Recommendations of ACOG and ACGM Augments Demand for CF Testing.......8
Ethical Issues & Need for Appropriate Regulating Policies.......8
1$100
   Routine Clinical Testing Vs. Predictive Genetic Testing.......9
Issues Related to Genetic Tests for Obesity.......9
1$100
   Competition.......10
Table 4: Leading Players in the Worldwide Genetic Testing Market (2006): Percentage Breakdown by Value Sales for Roche Diagnostics / Affymetrix, Abbott Laboratories, Bio-Rad Laboratories, and Others (includes corresponding Graph/Chart).......10
1$350
  3. PRODUCT OVERVIEW.......118 $595  
   Preface to Genetic Testing.......11
Genetic Testing and its Applications.......11
1$100
   Gene Candidate and Genome Screen.......12
‘DNA Chip’ to Chip into Genetic Field.......12
1$100
   Techniques Used to Identify Changes in Genes.......13
Types of Genetic Testing.......13
2$200
   Steps in Genetic Testing Process.......15
Limitations.......15
1$100
   Risks and Other Limitations of Genetic Testing.......16
Medical Institutions to Reap the Benefit of Genetic Testing.......16
Pharmacogenetics/Pharmacogenomics.......16
Review of Select Genetic Tests.......16
Cystic Fibrosis.......16
Breast and Ovarian Cancer.......16
1$100
   Alzheimer's Disease.......17
Colorectal Cancer.......17
Haemochromatosis (HH).......17
Cowden Syndrome.......17
Huntington's Disease.......17
1$100
   Costs of Select Tests.......18
Table 5: Costs of Select Genetic Tests.......18
1$350
  4. PRODUCT LAUNCHES.......199 $595  
   Health Diagnostic Laboratory Introduces CYP2C19 Genetic Test.......19
Response Genetics Introduces EML4-ALK Genetic Test.......19
Roche Launches GS Junior System.......19
Acton Biotech Introduces Genetic Test for Warfarin.......19
1$100
   Ambry Genetics Launches AmbryScreen.......20
Family Tree DNA Introduces Family Finder DNA Test.......20
Machaon Unveils Clinical Testing Service for Warfarin- Prescribed Patients.......20
Helicos BioSciences Develops MDx Tests.......20
1$100
   AccessDNA Launches Telephone Based Genetic Counseling Services.......21
DNA Genotek Unveils Performagene™ LIVESTOCK.......21
Equinome Introduces Speed Gene Test.......21
1$100
   Applied Biosystems Unveils 3500 Series and 3500 DX Series Genetic Analyzer.......22
Luminex Introduced New Range of Cystic Fibrosis Tests.......22
1$100
   Ambry Genetics Launches Whole-Genome Chromosomal Microarray Analysis.......23
Myriad Genetics Introduces OnDose for Cancer Diagnosis.......23
Xenomics to Introduce Innovative Gender Prediction Test.......23
1$100
   ParagonDx Offers Genetic Testing.......24
Interleukin Genetics Unveils Bone Health Genetic Test.......24
TessArae® Launches Human Genetic Disease Testing Solutions.......24
IBM to Develop Nanoscale DNA Sequencer.......24
1$100
   Response Genetics Unveils ResponseDX: Gastric™ Genetic Test Panel.......25
Axial Biotech Rolls out SCOLISCORE™ AIS Prognostic Test.......25
CyGene Laboratories Launches Predictive Genetic Products in Russia.......25
Cepheid Releases Xpert® BCR-ABL Monitor Test.......25
Interleukin Genetics Introduces Inherent Health™ Brand of Genetic Tests.......25
1$100
   PGxHealth Introduces FAMILION® DCM Test.......26
Correlagen Diagnostics Launches CardioGeneScan Test.......26
PsoriasisDX Introduces Genetic Test for Psoriatic Arthritis.......26
Clinical Data Introduces Genetic Test for HCM.......26
Iverson Genetic Diagnostics Unveils Warfarin Sensitivity Tests.......26
1$100
   HairDX Unveils New Test for Predicting Female Hair Loss.......27
HairDX Introduces Genetic Test for Male Baldness.......27
1$100
  5. PRODUCT LAUNCHES/INNOVATIONS IN RECENT PAST – A PERSPECTIVE BUILDER.......284 $295  
   Clinical Data Introduces Pharmacogenetic Test for Clozapine.......28
Seegene Launches 18-Plex Genotyping Test.......28
InterGenetics Introduces Onco Vue.......28
1$100
   Applied Biosystems Introduces Novel DNA Technologies.......29
Dabur Introduces CML Quest.......29
deCODE Launches deCODE T2.......29
DNAPrint Announces the Launch of Ancestry Indicator.......29
1$100
   Genzyme Unveils New Mutation Analysis Test.......30
Orchid BioSciences Introduces New Testing Kit.......30
Focus Diagnostics Introduces GenomEx(TM) Service.......30
Relative Genetics Introduces Y-chromosome haplogroup Service on Web Site.......30
1$100
   Genzyme Unveils Upgraded CFplus Cystic Fibrosis (CF) Mutation Analysis.......31
TMC Introduces AJP.......31
Genaissance Rolls Out FAMILION Test.......31
Tm Bioscience Rolls Out Tag-It Mutation Detection Kits.......31
1$100
  6. RECENT INDUSTRY ACTIVITY.......3216 $950  
   Transgenomic Licenses Intellectual Property from Integragen.......32
Signal Genetics Collaborates with Array BioPharma.......32
Genzyme Divests Genetic Testing Business.......32
Fujirebio to Take over Innogenetics.......32
1$100
   Response Genetics Inks License Agreement with GSK.......33
Response Genetics and Genetic Technologies Sign Distribution Pact.......33
Thermo Fisher Scientific Inks Agreement to Acquire Finnzymes.......33
1$100
   Fluidigm Enters into Partnership with IntegraGen.......34
Genetic Technologies Takes Over Assets of Perlegen Sciences.......34
Orchid Cellmark Acquires Paternity and Immigration DNA Testing Business Division of
  Strand Analytical Laboratories.......34
Al Borg Laboratories Acquires Majority Stake in Medical Genetics Center.......34
1$100
   BioReference Laboratories Takes Over Lenetix Medical Screening Laboratory.......35
PerkinElmer to Acquire Signature Genomic Laboratories.......35
Xenomics Changes Name to TrovaGene.......35
BioServe Signs Agreement with NGC Medical.......35
1$100
   Roche Signs Agreement with IBM.......36
DermaGenoma Merges with Developer of Dermatology Genetic Tests.......36
USDA Purchases Fluidigm EP1 System.......36
XDx and Bristol-Myers Squibb Company Signs Collaborative Agreement.......36
1$100
   Commonwealth Biotechnologies Divests Assets of Bioanalytical and Genetic Testing
  Business.......37
QIAGEN Takes Over DxS.......37
1$100
   Perkinelmer Takes Over Genetic Screening Business of Surendra Genetic Labs.......38
Interleukin Genetics Inks Licensing Agreement with LABEC Pharma.......38
deCODE Genetics Inks Licensing Agreements with Celera.......38
Gen-Probe Life Sciences Acquires Tepnel Life Sciences.......38
1$100
   ARCA Biopharma Merges with Nuvelo.......39
Berkeley HeartLab Enters into Partnership with GenVault.......39
CVS Collaborates with Generation Health to Expand PGx Testing.......39
Oman LNG and Omani Health Ministry Ink Agreements.......39
1$100
   Aurora and Celera Ink Agreement to Integrate Genetic Testing.......40
Interleukin Genetics Sells Assets of Alcan James Group.......40
PharmaGenoma Launches HairDX Europe.......40
SeqWright Collaborates with PharmaGenoma.......40
1$100
   PGxHealth Signs Contract with BCBSA.......41
Sequenom Takes Over SensiGen.......41
SCMM and PDI Sign Agreement for Sales Infrastructure.......41
Interleukin Receives Approval for Sale of PST® Test in New York.......41
1$100
   Interleukin Receives Approval for Sale of PST® Test in New York.......42
Medison Inks Agreement for Exclusive Representation of GeneXpert in Israel.......42
Surelab and Ambica Launch Genetic Testing in Davao City.......42
Correlagen Diagnostics Acquires Helicos® Genetic Analysis System.......42
1$100
   Quest to Carry out Genetic Tests on Patients at Scripps Health.......43
Biotage Sells Biosystems Division to QIAGEN.......43
Pfizer Animal Health to Take Over Bovigen and Catapult Genetics.......43
1$100
   DNA Testing Systems Inks Agreement with DNAPrint Genomics.......44
PerkinElmer Acquires Newborn Metabolic Screening Assets of Pediatrix.......44
Hologic Acquires Third Wave.......44
Dako Denmark Receives FDA Approval for TOP2A FISH pharmDx Device.......44
1$100
   Abbott Partners with Roche, OSI and Genentech.......45
Lab21 Partners with Amgen.......45
Medical Solutions Acquires Autogen Bioclear.......45
1$100
   Nanobac to Acquire DNAPrint Genomics.......46
HairDX and Bosley Join Hands for Offering Genetic Test for Baldness.......46
1$100
   Nioxin Inks Agreement with HairDX.......471$100
  7. CORPORATE ACTIVITY IN THE RECENT PAST – A PERSPECTIVE BUILDER.......4815 $950  
   Orchid Cellmark Acquires ReliaGene Technologies.......48
Celera Takes Over Atria Genetics.......48
Roche Acquires 454 Life Sciences.......48
BioServe and DNAPrint Genomics Form Strategic Alliance.......48
1$100
   Gentris Divests Stake in Genetic Testing Unit.......49
LabCorp Announces Genetic Test Partnership for Bucindolol Prescription.......49
Newsham Genetics Takes Over Monsanto Choice Genetics.......49
1$100
   BioServe Takes Over Genomics Collaborative.......50
CytoDyn Completes Acquisition of Advanced Genetic Technologies.......50
Sorenson Genomics Takes Over Identigene.......50
Clinical Data Enters into a License Agreement with VCGS.......50
1$100
   Clinical Data Collaborates with George Washington University.......51
Luminex Takes Over TM Bioscience.......51
Schering-Plough Enters into a Contract with Warnex.......51
1$100
   Cepheid Acquires Sangtec.......52
Medco Collaborates with Mayo.......52
Lab21 to Offer CLDA’s Genetic Test for Cardiac Channelopathy.......52
Clinical Data Pockets Epidauros Biotechnologie.......52
1$100
   Beijing Adinovo Gene and GENDIA Ink Genetic Test Exchange Agreement.......53
Genetic Technologies Forms Alliance with UTEK.......53
QIAGEN Acquires Digene.......53
1$100
   Luminex Inks Development Licensing Agreement with Mayo Clinic.......54
Manipal Joins Hands with NorDiag.......54
Orchid BioSceinces Enters into an Agreement with Prion Diagnostica.......54
1$100
   DNAPrint™ genomics to Purchase Ellipsis.......55
Tm Bioscience Inks a Pact with Maxxam Analytics.......55
DNAPrint genomics Takes Over Trace Genetics.......55
Roche Diagnostics Inks a Licensing Agreement with Innogenetics.......55
Clinical Data Purchases Genaissance Pharmaceuticals.......55
1$100
   Illumina Pockets CyVera Corporation.......56
Orchid Cellmark Inks Contract with Merial.......56
Sequenom Gains Noninvasive Prenatal Diagnostic IP Rights from Isis.......56
TMC Inks a Pact with ARUP Laboratories.......56
Specialty Laboratories Accords with Roche.......56
TMC Ceases Licensing Agreement with Abbott.......56
1$100
   Correlagen Diagnostics Collaborates with Children's Hospital Boston.......57
Edith Cowan University Strikes Deal with Solbec.......57
InterGenetics Join Hands with i.d.e.a.s........57
Clinical Data Acquires Icoria.......57
SomaLogic Strikes a Deal with Quest Diagnostics.......57
DNAPrint Bags Grant from the Federal Government.......57
1$100
   Tepnel Acquires Orchid’s Diagnostic Unit.......58
Lark Tech. Merges with Genaissance.......58
PRF in Alliance with Sydney Biotech.......58
Osmetech and LGC Sign Licensing Pact.......58
TMC Signs a Pact with LabOne.......58
Abbott in Agreement with Atria.......58
1$100
   Third Wave Grants Marketing and Distribution Rights to Innogenetics.......59
Orchid Bags Deal to Provide Testing Services for Immigrants to New Zealand.......59
Tm Bioscience Contracts with Pharmacogenetics.......59
Genetic Technologies Grants License to Genzyme.......59
1$100
   New Genetic Testing Identifies Gene Responsible for Alzheimer Disease.......60
Roche Licenses GeneChip® Technology from Affymetrix.......60
Genaissance Acquires DNA Sciences.......60
GTG Joins GENDIA Diagnostic Genetic Testing Network.......60
Arch Collaborates with GeneLink to Market Formulations.......60
1$100
   Roche Diagnostics and GIS to Develop SARS Detection Kit.......61
Roche Diagnostics in Agreement with Innogenetics.......61
Cenetron in Alliance with Roche Diagnostics.......61
Gribbles Establishes Gribbles Molecular Science, a New Genetic Testing Firm.......61
Roche the First to Receive Clearance for Thrombophilia Genetic Disorder Tests.......61
1$100
   Roche and DeCode Develop DNA-based Tests to Foretell Behavior.......62
Roche and deCODE Discover Changes in Gene Responsible for Osteoporosis.......62
Roche and deCODE Announce Discovery of New Gene Structures.......62
Mayo Contracts with Tm Bioscience.......62
1$100
  8. TECHNOLOGICAL DEVELOPMENTS IN THE RECENT PAST – A PERSPECTIVE BUILDER.......631 $100  
   New Molecular Diagnostic device to Improve Genetic Tests for Alzheimer disease.......63
Deakin Clinic Offers PGD, a Sophisticated Testing for Genetic Disorders.......63
New Gene Mapping Method to Enhance Identification of Haplotype Block.......63
New Non-Invasive test a Better Indicator of Malignancy than the PSA Test.......63
1$100
  9. FOCUS ON SELECT GLOBAL PLAYERS.......644 $295  
   Abbott Laboratories (USA).......64
Abbott Molecular, Inc. (USA).......64
Applied Biosystems Inc. (USA).......64
1$100
   AutoGenomics, Inc. (USA).......65
BioRad Laboratories (USA).......65
Celera Group (USA).......65
Clinical Data, Inc. (USA).......65
1$100
   Orchid Cellmark, Inc. (USA).......66
PerkinElmer, Inc. (USA).......66
Quest Diagnostics, Inc. (USA).......66
1$100
   Roche Diagnostics Corp. (Switzerland).......67
Roche Molecular Diagnostics, Inc. (USA).......67
1$100
  10. GLOBAL MARKET PERSPECTIVE.......68   
   Table 6: World Recent Past, Current & Future Market Analysis for Genetic Testing by Geographic Region – US, Canada,Japan, Europe and Rest of World Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......681$350
   Table 7: World Historic Review for Genetic Testing by Geographic Region – US, Canada, Japan, Europe and Rest of World Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......691$350
   Table 8: World 11-Year Perspective for Genetic Testing by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......701$350
  11. THE UNITED STATES.......716 $950  
   A. Market Analysis.......71
Current and Future Analysis.......71
Newborn Testing Gain Ground.......71
Table 9: US Prenatal and Newborn Genetic Testing Market (2007-2015): Annual Sales in US$ Million (includes corresponding Graph/Chart).......71
1$350
   Predictive Screening: Another Growth Area.......72
Direct-to-Consumer Testing - A Growing Market.......72
1$100
   US Regulatory Environment.......73
Genetic Testing Set for Big Boost with New Legislation.......73
DNA-Based Testing to Move Beyond Research Laboratories.......73
1$100
   Key and Emerging Players in US.......74
Genova Diagnostics.......74
InterGenetics.......74
Myriad Genetics, Inc........74
1$100
   Nanogen, Inc........75
B. Market Analytics.......75
Table 10: US Recent Past, Current & Future Analysis for Genetic Testing by Segment–Pharmacogenomic Testing, Prenatal and Newborn Genetic Testing, and Predictive Medicine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......75
1$350
   Table 11: US Historic Review for Genetic Testing by Segment–Pharmacogenomic Testing, Prenatal and Newborn Genetic Testing, and Predictive Medicine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......76

Table 12: US 11-Year Perspective for Genetic Testing by Segment–Pharmacogenomic Testing, Prenatal and Newborn Genetic Testing, and Predictive Medicine Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).......76
1$350
  12. CANADA.......772 $595  
   A. Market Analysis.......77
Canada, the Market to be Watched Out for.......77
Key Player.......77
Luminex Molecular Diagnostics.......77
B. Market Analytics.......77
Table 13: Canadian Recent Past, Current & Future Analysis for Genetic Testing – Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......77
1$350
   Table 14: Canadian Historic Review for Genetic Testing – Annual Sales Figures with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......781$350
  13. JAPAN.......792 $595  
   Market Analysis.......79
Table 15: Japanese Recent Past, Current & Future Analysis for Genetic Testing – Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........79
1$350
   Table 16: Japanese Historic Review for Genetic Testing – Annual Sales Figures with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......801$350
  14. EUROPE.......814 $595  
   A. Market Analysis.......81
A Brief Overview of Legislations/Regulatory Policies in Select European
  Countries.......81
Government Encourages Genetic Testing in UK.......81
1$100
   Italy.......82
Top Prenatal Genetic Tests Conducted in Italy, by Volume (2004): A Recent Past
  Perspective.......82
Top Postnatal Genetic Tests Conducted in Italy, by Volume (2004): A Recent Past
  Perspective.......82
1$100
   Key and Emerging Players in Europe.......83
B. Market Analytics.......83
Table 17: European Recent Past, Current & Future Analysis for Genetic Testing – Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........83
1$350
   Table 18: European Historic Review for Genetic Testing – Annual Sales Figures with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......841$350
  15. REST OF THE WORLD.......852 $395  
   A. Market Analysis.......85
Asia & Latin America: The Future Market for Genetic Testing.......85
Approval of Experiments on Human Embryos in New Zealand.......85
Singapore Sets Guidelines for Genetic Research and Testing.......85
1$100
   B. Market Analytics.......86
Table 19: Rest of World Market for Genetic Testing - Recent Past, Current & Future Analysis with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......86

Table 20: Rest of World Market for Genetic Testing Historic Review with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......86
1$350
COMPETITION 259$995
  
Total Companies Profiled: 77 (including Divisions/Subsidiaries - 86)

Region/Country                 Players


The United States                 63    
Canada                             4
Europe                            16 
     Germany                       3
     The United Kingdom            5
     Rest of Europe                8
Asia-Pacific (Excluding Japan)     3
Click here to request a full table of contents and more details on this project.		  
 
 

© Global Industry Analysts, Inc., USA. All Rights Reserved.
Visa Master American Verisign